New Horizons- Translational Aspect of Osteomorphs.
Kyung-Hyun Park-MinSe Hwan MunRichard BockmanMichelle Maree McDonaldPublished in: The Journal of clinical endocrinology and metabolism (2023)
Osteomorphs are a newly described osteoclast lineage cell in mice, which are suggested to play a significant role in the maintenance of bone resorption. Pre-clinical investigations revealed that osteomorphs are generated through the fission of multinucleated bone-resorbing osteoclasts and can also re-fuse with existing osteoclasts. Modifications to RANKL signaling has been shown to alter cycles of fission and re-fusion of osteomorphs in mice. These novel findings were also shown to contribute to the rebound phenomenon after cessation of anti-RANKL therapy in mice. Moreover, the absence of osteomorph-specific genes in mice exhibits bone structural and quality phenotypes. Given these insights, it could be speculated that osteomorphs play a significant role in bone homeostasis, bone metabolic diseases, and response to therapeutics. In this review, we discuss these potential translational roles for osteomorphs. Importantly, we highlight the need for future pre-clinical and clinical studies to verify the presence of osteomorphs in humans and explore further the translational implications of this discovery.